RRML - Acquired Angioedema Due to C1 inhibitor Deficiency Caused by Non-Hodgkin Lymphoma in a Patient with Myasthenia Gravis
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2020): 1.027

Rejection rate (2020): 75%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- November 2021 -
 
Cell Cycle Regulatory CCND1 G8... 19
COVID-19 associated coagulopat... 19
Romanian Review of Laboratory ... 13
The Effect of Resveratrol on S... 11
Acquired Angioedema Due to C1 ... 10
Circulating amino acids as fin... 10
Mutations in the KRAS gene as ... 9
Evaluation of Plasma AA/DHA+EP... 6
Genetic Diagnostic Approaches ... 6
Atellica CH 930 chemistry anal... 6

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 29(4)/2021 DOI:10.2478/rrlm-2021-0029
XML
TXT

Case report

Acquired Angioedema Due to C1 inhibitor Deficiency Caused by Non-Hodgkin Lymphoma in a Patient with Myasthenia Gravis

Noémi Bara, Valentin Nadasan, Lilian Varga, Henriette Farkas

Correspondence should be addressed to: Valentin Nadasan

Abstract:

Acquired angioedema due to C1-inhibitor deficiency is a very rare disorder that usually appears in patients with lymphoproliferative and/or autoimmune diseases. This type of swelling is bradykinin mediated and does not respond to antihistamines, corticosteroids, or epinephrine. The symptoms usually appear in patients older than 40 years with recurrent episodes of angioedema without wheals. The family history is negative. The swelling could affect any tissue, but most frequently is located at the face, lips, tongue, larynx, or extremities. In the gastrointestinal tract, it causes pain, nausea, vomiting, and diarrhea. The upper respiratory airway oedema is a potentially life-threatening condition due to asphyxiation. The oedema attacks may precede the symptoms of the causative disease for months or years. In most cases, the treatment of the underlying disease resolves the angioedema episodes. Here we report a case of C1-INH-AAE caused by non-Hodgkin lymphoma in a patient diagnosed many years before with myasthenia gravis whose angioedema symptoms resolved after the specific treatment of lymphoma.

Keywords: rare disease, bradykinin mediated angioedema, lymphoproliferative disease, autoimmune disease, angioedema attack

Received: 7.9.2021
Accepted: 23.92021
Published: 29.9.2021

 
  PDF Download full text PDF
(308 KB)
  PDF Download erata
(238 KB)
     
 
How to cite
Bara N, Nadasan V, Varga L, Farkas H. Acquired Angioedema Due to C1 inhibitor Deficiency Caused by Non-Hodgkin Lymphoma in a Patient with Myasthenia Gravis. Rev Romana Med Lab. 2021;29(4):453-6. DOI:10.2478/rrlm-2021-0029